β-Blockers Linked to Reduced Mortality in HFrEF, A-Fib

Share this content:
β-Blockers Linked to Reduced Mortality in HFrEF, A-Fib
β-Blockers Linked to Reduced Mortality in HFrEF, A-Fib

THURSDAY, Jan. 12, 2017 (HealthDay News) -- β-blockers are associated with significantly reduced mortality, but not hospitalizations, in patients with heart failure and reduced ejection fraction (HFrEF) and atrial fibrillation (AF), according to a study published online Jan. 11 in JACC: Heart Failure.

Julia Cadrin-Tourigny, M.D., from the Université de Montréal, and colleagues examined the impact of β-blockers on mortality and hospitalizations in patients with AF and HFrEF in the AF-CHF trial. Among 1,376 subjects randomized in the trial, the authors propensity-matched those without β-blockers at baseline to a maximum of two exposed patients.

The researchers found that β-blockers correlated with significantly lower all-cause mortality (hazard ratio [HR], 0.721; 95 percent confidence interval [CI], 0.549 to 0.945; P = 0.0180) but not hospitalizations (HR, 0.886; 95 percent CI, 0.715 to 1.100; P = 0.2232) during a median follow-up of 37 months. In sensitivity analyses that modeled β-blockers as a time-dependent variable the results were similar (HR for all-cause mortality, 0.668; 95 percent CI, 0.511 to 0.874; P = 0.0032; HR for hospitalizations, 0.814; 95 percent CI, 0.653 to 1.014; P = 0.0658). With respect to mortality and hospitalizations, there were no significant interactions for β-blockers and pattern or burden of AF.

"These results support current evidence-based recommendations for β-blockers in patients with HFrEF, whether or not they have associated AF," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Pediatricians Should Provide Sexual Health Care Services

Pediatricians Should Provide Sexual Health Care Services

Office visits present opportunity to provide comprehensive education and health care services

Guidelines Updated for Infection Prevention in Pediatrics

Guidelines Updated for Infection Prevention in Pediatrics

Update focused on key principles of infection prevention, control relevant to ambulatory patients

2003 to 2014 Saw Drop in Urinary Arsenic in Public Water Users

2003 to 2014 Saw Drop in Urinary Arsenic ...

Reduction occurred after implementation of EPA's maximum contaminant level for arsenic

is free, fast, and customized just for you!

Already a member?

Sign In Now »